S
AGIO icon

SignatureFD’s Agios Pharmaceuticals AGIO Stock Holding History

SignatureFD’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Hold
399
– – ﹤0.01% 2479
2026
Q1 		$13.5K Hold
399
– – ﹤0.01% 2380
2025
Q4 		$10.9K Sell
399
-114
-22% -$4K ﹤0.01% 2396
2025
Q3 		$20.6K Hold
513
– – ﹤0.01% 2101
2025
Q2 		$17.1K Buy
513
+36
+8% +$1.09K ﹤0.01% 2124
2025
Q1 		$14K Sell
477
-34
-7% -$1.13K ﹤0.01% 2228
2024
Q4 		$16.8K Buy
511
+11
+2% +$517 ﹤0.01% 2141
2024
Q3 		$22.2K Buy
500
+12
+2% +$545 ﹤0.01% 1990
2024
Q2 		$21K Sell
488
-5
-1% -$180 ﹤0.01% 1944
2024
Q1 		$14.4K Sell
493
-200
-29% -$5.36K ﹤0.01% 2164
2023
Q4 		$15.4K Buy
693
+22
+3% +$493 ﹤0.01% 2054
2023
Q3 		$16.6K Sell
671
-68
-9% -$1.8K ﹤0.01% 1947
2023
Q2 		$20.9K Sell
739
-28
-4% -$697 ﹤0.01% 1860
2023
Q1 		$17.6K Sell
767
-214
-22% -$5.68K ﹤0.01% 1938
2022
Q4 		$27.5K Sell
981
-22
-2% -$620 ﹤0.01% 1649
2022
Q3 		$28K Buy
1,003
+482
+93% +$12.9K ﹤0.01% 1571
2022
Q2 		$12K Buy
521
+402
+338% +$9.08K ﹤0.01% 2016
2022
Q1 		$3K Buy
119
+74
+164% +$2.26K ﹤0.01% 2649
2021
Q4 		$1K Sell
45
-28
-38% -$1.13K ﹤0.01% 2857
2021
Q3 		$3K Sell
73
-105
-59% -$5.07K ﹤0.01% 2493
2021
Q2 		$10K Buy
178
+68
+62% +$3.8K ﹤0.01% 1968
2021
Q1 		$6K Buy
110
+37
+51% +$1.83K ﹤0.01% 2044
2020
Q4 		$3K Hold
73
– – ﹤0.01% 2097
2020
Q3 		$3K Buy
73
+35
+92% +$1.53K ﹤0.01% 2039
2020
Q2 		$2K Buy
38
+2
+6% +$93 ﹤0.01% 2072
2020
Q1 		$1K Sell
36
-18
-33% -$832 ﹤0.01% 2056
2019
Q4 		$3K Buy
54
+36
+200% +$1.36K ﹤0.01% 1746
2019
Q3 		$1K Sell
18
-31
-63% -$1.28K ﹤0.01% 1907
2019
Q2 		$2K Buy
49
+21
+75% +$1.12K ﹤0.01% 1733
2019
Q1 		$2K Buy
+28
New +$1.63K ﹤0.01% 1748

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

SignatureFD's AGIO Position: Q2 2026 in Review

SignatureFD held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 399 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

SignatureFD first reported a position in AGIO in Q1 2019 and has held it in 30 quarters since. The position peaked at $28K in Q3 2022. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • SignatureFD held 399 shares of Agios Pharmaceuticals worth $14.8K as of Q2 2026.
  • SignatureFD left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2479 holding.
  • SignatureFD first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
  • SignatureFD's Agios Pharmaceuticals position peaked at $28K in Q3 2022.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.